Dr. Sreenivasa Chandana, M.D., Ph.D.
Claim this profileSTART Midwest
Area of expertise
Colorectal Cancer
Sreenivasa Chandana, M.D., Ph.D. has run 2 trials for Colorectal Cancer. Some of their research focus areas include:
Biliary Tract Cancer
Sreenivasa Chandana, M.D., Ph.D. has run 2 trials for Biliary Tract Cancer. Some of their research focus areas include:
Affiliated Hospitals
START Midwest
Cancer And Hematology Centers Of Western Michigan, PC
Clinical Trials Sreenivasa Chandana, M.D., Ph.D. is currently running
DCC-3116 + Anticancer Therapies
for Advanced Cancers
This is a Phase 1/2, multicenter, open-label (unless otherwise specified in a combination-specific module) study of inlexisertib in combination with anticancer therapies. Modules within the master protocol are defined according to different combinations of inlexisertib with other anticancer agents.
Recruiting
1 award
Phase 1 & 2
QN-302
for Advanced Cancer
This trial is testing a drug called QN-302 in patients with advanced or metastatic solid tumors. The drug is given through an IV on a regular schedule. Researchers want to learn how the drug affects the body and how the body processes it, while also ensuring it is safe for patients.
Recruiting
1 award
Phase 1
2 criteria
More about Sreenivasa Chandana, M.D., Ph.D.
Clinical Trial Related
6 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Sreenivasa Chandana, M.D., Ph.D. has experience with
- Gemcitabine
- Nab Paclitaxel
- NovoTTF-100L(P)
- NovoTTF-200T
- Bevacizumab
- Capecitabine
Breakdown of trials Sreenivasa Chandana, M.D., Ph.D. has run
Colorectal Cancer
Biliary Tract Cancer
Pancreatic Adenocarcinoma
Stomach Cancer
Esophageal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sreenivasa Chandana, M.D., Ph.D. specialize in?
Sreenivasa Chandana, M.D., Ph.D. focuses on Colorectal Cancer and Biliary Tract Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Sreenivasa Chandana, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Sreenivasa Chandana, M.D., Ph.D. is currently recruiting for 2 clinical trials in Grand Rapids Michigan. If you're interested in participating, you should apply.
Are there any treatments that Sreenivasa Chandana, M.D., Ph.D. has studied deeply?
Yes, Sreenivasa Chandana, M.D., Ph.D. has studied treatments such as Gemcitabine, nab paclitaxel, NovoTTF-100L(P).
What is the best way to schedule an appointment with Sreenivasa Chandana, M.D., Ph.D.?
Apply for one of the trials that Sreenivasa Chandana, M.D., Ph.D. is conducting.
What is the office address of Sreenivasa Chandana, M.D., Ph.D.?
The office of Sreenivasa Chandana, M.D., Ph.D. is located at: START Midwest, Grand Rapids, Michigan 49546 United States. This is the address for their practice at the START Midwest.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.